Ring Mountain Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Buy
330
+3
+0.9% +$3.06K 0.17% 66
2026
Q1
$301K Sell
327
-6
-2% -$6.08K 0.16% 71
2025
Q4
$346K Sell
333
-3
-0.9% -$2.87K 0.18% 71
2025
Q3
$256K Buy
336
+5
+2% +$3.72K 0.14% 84
2025
Q2
$255K Sell
331
-342
-51% -$266K 0.16% 82
2025
Q1
$556K Sell
673
-18
-3% -$15K 0.42% 42
2024
Q4
$533K Buy
+691
New +$572K 0.36% 45

Other funds holding LLY

Ring Mountain Capital's LLY Position: Q2 2026 in Review

Ring Mountain Capital increased its Eli Lilly (LLY) stake by 0.92% in Q2 2026, buying an estimated $3.06K and bringing the position to 330 shares worth $396K. The position accounts for 0.17% of the portfolio, ranked #66.

Ring Mountain Capital first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $556K in Q1 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ring Mountain Capital held 330 shares of Eli Lilly worth $396K as of Q2 2026.
  • Ring Mountain Capital bought 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.17% of Ring Mountain Capital's portfolio in Q2 2026, its #66 holding.
  • Ring Mountain Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Ring Mountain Capital's Eli Lilly position peaked at $556K in Q1 2025.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ring Mountain Capital's 13F filing for Q2 2026, filed 11 Aug 2026.